Aphex BioCleanse Systems (APHX) Plans Filing With Securities & Exchange Commission.

Aphex BioCleanse Systems Appoints Hancock Askew as New PCAOB-Qualified Auditor, Hires Accounting Consultant PITTSFORD, N.Y., Sept 14, 2020 /PRNewswire/ -- Aphex...

Immunomedics (IMMU) $3.00 to $88, Up 29-fold, Our Second Best Idea Ever.

Interesting Charts From the Day we Discovered it. Gilead Sciences, Inc. (Nasdaq: GILD) and Immunomedics (Nasdaq: IMMU) announced...
American BriVision

American BriVision’s (ABVC) Clinical Study Sparks Interest From Potential Partners.

Is Wall Street Missing American Brivision's Full Clinical Safety and Efficacy Study? We Think it has. Potential...
Internet Stock Review

Peleton (PTON) Hits $25 Billion Valuation. Calm (Private) Hits Unicorn Valuation at $1 Billion.

Home Fitness and Wellness Raging on Main Street and Wall Street. While 24 Hour Fitness Files for Bankruptcy..

Dow 36,000 – S&P 500 4,500 – NASDAQ 15,000. Then a Crash. David Hunter.

David Hunter, chief macro strategist at Contrarian Macro Advisors. Interesting interview with David Hunter, who predicts some awful things...
biotech stock review

Adding Fluidigm (FLDM) $6.14, to Corona Stock Watch List.

And we have our first 'bounce' candidate of the dip.. LIVE CHART
Inovie, Biotech Stock Review

Shorts Set $1.00 Price Target on Inovio (INO) $9.20.

Interesting battle brewing! LIVE CHART Inovio shares tumble 8%...

There’s Simply No Loyalty Anymore.

TODAY'S LETTER Frontier Bio (FBIO) $3.90. We Have Another Double! American BriVision (ABVC) $4.00. Wait, What? Yet...
Roland Rick Perry, Biotech Stock Review, Frontier Bio

And We Have Another Double. Frontier Bio (FBIO) Crosses $4.00.

Sometimes we Can't Beleive Our Luck Over the Last Couple Years. But There You Have it, at Least we Know It's...
Aphex BioCleanse

Aphex BioCleanse Hand Sanitizer Seeking FDA GRAS Approval.

Aphex BioCleanse Systems Enters Agreement with Now Biopharma for Hand Sanitizer Clinical Trial PITTSFORD, N.Y., Aug. 31, 2020 /PRNewswire/ -- Aphex...

Latest article

Nine Page Summary Report on GeoVax (GOVX)

This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

Award of BARDA Project NextGen contract represents a significant milestone event; Total value...